Arcus Biosciences - Stock Price History | RCUS

Historical daily share price chart and data for Arcus Biosciences since 2022 adjusted for splits. The latest closing stock price for Arcus Biosciences as of December 02, 2022 is 35.71.
  • The all-time high Arcus Biosciences stock closing price was 48.47 on November 23, 2021.
  • The Arcus Biosciences 52-week high stock price is 47.00, which is 31.6% above the current share price.
  • The Arcus Biosciences 52-week low stock price is 16.74, which is 53.1% below the current share price.
  • The average Arcus Biosciences stock price for the last 52 weeks is 29.05.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Arcus Biosciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 33.3197 26.1600 48.4700 22.7500 40.4700 55.89%
2020 21.5422 9.8600 36.5600 8.7800 25.9600 157.03%
2019 9.3063 10.6800 13.3800 6.4400 10.1000 -6.22%
2018 13.5637 17.0000 17.7100 9.7400 10.7700 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.586B $0.383B
Arcus Biosciences is a biopharmaceutical company. It focused on creating innovative cancer immunotherapies. The company's product portfolio includes AB928, AB122, AB154 and AB680. AB928 which is in its final phase is a potent and selective dual antagonist of the adenosine receptors. AB122 which is in its Phase1 is a monoclonal antibody which potently and selectively blocks a protein called PD-1. AB154 is a monoclonal antibody which potently and selectively blocks a novel immune checkpoint called TIGIT. AB680, which is in its Phase1 is a potent and selective inhibitor of CD73, the enzyme responsible for the extracellular production of adenosine within the tumor micro-environment. Arcus Biosciences is based in Hayward, CA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $172.495B 10.52
GSK (GSK) United Kingdom $71.890B 9.01
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.433B 19.52
Ginkgo Bioworks Holdings (DNA) United States $3.861B 0.00
Myovant Sciences (MYOV) United Kingdom $2.605B 0.00
Biohaven (BHVN) United States $1.141B 0.00
Emergent Biosolutions (EBS) United States $0.599B 4.71
Zymeworks (ZYME) Canada $0.478B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.278B 0.00
Enzo Biochem (ENZ) United States $0.096B 0.00
SQZ Biotechnologies (SQZ) United States $0.046B 0.00
Gelesis Holdings (GLS) United States $0.035B 0.00
Ambrx Biopharma (AMAM) United States $0.019B 0.00